FDA panel endorses coronavirus boosters for older adults and those at risk of serious disease
Posted on AllSides September 17th, 2021
From The Left
In an all-day FDA advisory meeting, experts unanimously recommended a coronavirus vaccine booster be authorized for people 65 and older and those at high risk of severe disease. The panel earlier resoundingly voted against approving Pfizer’s application for a broader approval of boosters for everyone 16 and older.
Expert advisers to the Food and Drug Administration are meeting Friday on the increasingly contentious issue of coronavirus vaccine boosters, the first phase of what could be a multiday effort to come up with government policy on who should get the extra...
Some content from this outlet may be limited or behind a paywall.